In 2024, India witnessed a vibrant year in the context of pharmaceutical industry, which was an innovative, challenging and growth orientated year. The sector cemented its position as a global healthcare hub as the domestic market continued to grow steadily with the exports picking up momentum. The Indian pharmaceutical market is projected to grow by double in the next 10 years. Rising healthcare awareness, urbanization, as well as government initiatives like Ayushman Bharat and Jan Aushadhi schemes boosted domestic demand and the impact of these schemes saw a significant upswing. While robust, export growth was hit by regulatory scrutiny and pricing pressures in the U.S., the market of paramount importance for Indian generic drugs.
The industry was open to the newest trends, including personalized medicine, digital therapeutics to enhance treatment precision and patient outcomes. Genomics and biomarkers allowed for investment, tailoring therapy specifically in oncology. In particular, digital healthcare technologies, including telehealth and remote patient monitoring became core, enabling both increased care access and engagement with patients.
Production-Linked Incentive (PLI) scheme helped India push Active Pharmaceutical Ingredients (API) production amid strengthening, and less reliance on Chinese imports. Firms successfully began adopting green manufacturing practices in order to focus on environmental...
Fort Herbal Drugs | Transforming consumer perspectives and conse¬quently changing preferences are driving a trend towards natural medicines and holistic wellness, thereby fueling the growth of the herbal medicines market. | |
Salud Care | According to industry experts, the market for cardio-vascular, anti-diabetic and dermatological range of medications is growing rapidly influenced by a number of factors. | |
SS Worldwide Logistics | In the pharmaceutical industry, where the safe and timely delivery of life-saving medications and sensitive medical supplies is critical, logistics is not just about moving goods from point A to point B. | |
Venkata Narayana Active Ingredients (VNAI) | The active pharmaceutical ingredient (API) market in India is poised for remarkable growth, driven by backward integration and adherence to stringent quality standards. | |
Waxoils | The landscape of pharmaceutical excipients is experiencing a dynamic advancement, driven by factors like increasing drug development, and emphasis on high-quality ingredients | |
OneCell Diagnostics | Despite being in the news for a lot of positive reasons lately, India is also slowly gaining the ill-fame of being called the ‘Cancer Capital of the World’. Improper diet intake, sedentary lifestyles, increased exposure to pollution |